Dr. Gregoire H. Bergier, MD

Dr. Bergier practices at BayCare Mease Countryside Hospital in Safety Harbor, Florida, part of BayCare Health System.

Dr. Bergier's NPI, 1528098720, was assigned on July 3, 2006. Dr. Bergier graduated from University of Lausanne Faculty of Medicine in 1995. Dr. Bergier holds Florida license ME83866.

Dr. Bergier's primary practice is BayCare Mease Countryside Hospital, at 3231 McMullen Booth Rd, Safety Harbor, FL 34695 in Pinellas County. The practice phone is (727) 734-6950.

Dr. Bergier's primary practice is BayCare Mease Countryside Hospital in Safety Harbor, Florida, part of BayCare Health System. Dr. Bergier is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Bergier to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergier practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Bergier's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Bergier is board certified in medical oncology by the American Board of Internal Medicine. Dr. Bergier is licensed in Florida.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Bergier treats.

CMS data shows 83,490 Medicare services from Dr. Bergier across 36 procedure codes in 2024, for 642 Medicare patients. Medicare paid $324,320 for them. Every service was in an office.

CMS counts 642 Medicare patients who saw Dr. Bergier in 2024. The largest group is 75 to 84, with 264 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bergier's median patient age at 69, with 64% women.

In 2024, Dr. Bergier wrote 1,487 Medicare Part D claims for 255 patients. 69% of them were for generic drugs. CMS names the drug for 1,100 of them, across 36 drugs with 11 or more claims each, at $3,215,156 in total drug cost. In 2023, CMS named 1,271 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bergier for performance year 2024, reported as part of a group. Dr. Bergier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bergier as offering telehealth.

CMS Open Payments shows 726 general payments to Dr. Bergier from 63 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,713.

Dmand AI lists 1 award for Dr. Bergier, most recently CMS Stage 1 EHR in 2014.

Dr. Bergier graduated from University of Lausanne Faculty of Medicine in 1995.

Dr. Bergier is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.